CU's GeneSpector introduces new kits to detect Covid-19 ****************************************************************************************** * CU subsidiary GeneSpector introduces new kits to detect Covid-19 ****************************************************************************************** Technology to diagnose, safely isolate and neutralise Covid samples was developed at Charl GeneSpector, a subsidiary company of Charles University making use of technology developed introduced new kits for more efficient, faster, and safer laboratory detection of Covid-19 benefits, the firm stressed in a press release on Tuesday, is the ability in the new kits viRNAtrap fluid to inactivate and preserve virus samples, rendering them safe for further By October, the firm plans to release kits which will be able to detect, in parallel, the two most widespread flu strains, influenza A and B. The availability of both should make i symptoms are related to the novel coronavirus or the flu. GeneSpector was founded as a spin-off from CU by Charles University Innovations Prague (CU commercial partners. GeneSpector said it is focusing on the whole diagnostic process, allo laboratories, no matter how large or small, to diagnose COVID-19 and other viral infection of the technology, Professor Stanislav Kmoch from the First Faculty of Medicine at Charles up the positive characteristics: "When the solution comes in contact with a nasopharynx sw immediately denaturates the viral particle. Thus, the sample becomes non-infectious and it without the risk of a transmission to medical and laboratory personnel." The unique sampling set is accompanied by an isolation and detection kit developed by comm involved in the project: sample isolation takes less than 15 minutes and is compatible wit instruments on the market. This ensures an immediate applicability in all laboratories equ real-time PCR cycler within the Czech Republic and abroad. GeneSpector says it thus provid solution covering the process from sampling to results, which is already available for pur following this link: https://www.genespector.com [ URL "https://genespector.com/"] /. Mich of the newly founded company, summed up main advantages of the prepared kits: "Thanks to the unique sampling medium viRNAtrap, we provide safety to laboratory personnel able to provide results in less than 90 minutes after receiving a sample for testing. Addi handle a series of 94 samples at once. This is going to lift the strain off analytical lab their capacities, all that for a price affordable for any laboratory in the Czech Republic In the autumn, the hope is that the fast diagnostic will be accompanied by the possibility and Influenza A and B within one analytical run. "The whole project is a nice example showing how to transfer knowledge into practice and m process. By connecting with active investors financing and coordinating the enterprise, we at Charles University a chance to focus on their research without being distracted by comm tasks," Otomar Sláma, director of CUIP, said. In recent years, knowledge transfer has been of Charles University and CUIP to bring important technology to the market, safely and fas benefits are accessible sooner than might have been the case in the past. Technology developed by Professor Kmoch and his team, the university points out, was suppo grant programme provided by the Technology Agency of the Czech Republic (TA CR). Charles U part in March call for projects, through which the TA CR provided support for research act to COVID-19. Charles University Innovations Prague s.r.o. CUIP is a wholly owned subsidiary of the Charles University founded in June 2018. It is a knowledge dissemination organisation, whose primary goal is to widely disseminate results Charles University and to secure utilisation of intellectual property of the Charles Unive field of research and development and its use for business, industrial, and other similar their commercialisation. CUIP can establish or buy shares in spin-off companies in order t utilise intellectual property of the Charles University. Within this field, CUIP closely c the Centre for Knowledge and Technology Transfer of the Charles University, which is a sta of the Charles University and provides services and information supporting the transfer of technology. In 2020, CUIP has already founded two spin-off companies – Charles Games s.r.o. programmin computer games and LAM¬ X a.s. developing nanomaterial capable of active defence against a pathogens. For more info visit: https://www.cuip.cz [ URL "www.cuip.cz"] . Commercial partners with GeneSpector on the new kits for the detection of Covid-19 GENERI BIOTECH s.r.o. GB was founded in 1995 as a producer of oligonucleotides. Their know-how covering synthesi oligonucleotide modifications translated into development of real-time PCR IVD kits and th IVD kits steadily grows since 2010. GB's products are used in laboratory diagnostics in hu R&D. For more info visit: https://www.generi-biotech.com [ URL "http://www.generi-biotech.com"] SPADIA LAB, a.s. SPADIA LAB, a network of diagnostic laboratories founded in 2009, is one of the largest pr laboratory medicine in the Czech Republic. It provides a spectrum of routine, highly speci unique examinations. They are accredited following a norm ČSN EN ISO 15189:2013. They are COVID-19 testing by the State Health Department (www.szu.cz/tema/prevence/laboratorni-vyse covid-19-2). Their significant capacity allows high speed of sample work-up and quality of is crucial for proper patient care in both prevention and treatment. For more info visit: https://www.spadia.cz [ URL "http://www.spadia.cz"] . ZKV Career, s.r.o. ZKV Career was founded in 2017 and focuses on consulting services for new companies, espec stages – the inception, search for investors, and creation of business and marketing strat companies as consultants and interim managers in the field of management, marketing, busin resources. For more info visit: https://zkvcareer.com [ URL "https://zkvcareer.com"] .